A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephr
about
A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephr
description
clinical trial
@en
klinisch onderzoek
@nl
name
A Paroxetine- and Placebo-Cont ...... RIs) and Serotonin Norepinephr
@en
type
label
A Paroxetine- and Placebo-Cont ...... RIs) and Serotonin Norepinephr
@en
prefLabel
A Paroxetine- and Placebo-Cont ...... RIs) and Serotonin Norepinephr
@en
P4844
P6153
P1476
A Double-Blind, Paroxetine- an ...... essant Effects - TRIADE Study)
@en
P3098
NCT01318434
P4844
P580
2011-02-01T00:00:00Z
P582
2013-02-01T00:00:00Z